International Prostate Symptom Score

Known as: I-PSS, IPSS 
A screening tool used to screen for, diagnose, track, and manage the symptoms of benign prostatic hyperplasia.
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

Secondary hypothyroidism

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled…
BACKGROUND Tadalafil improved lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH; LUTS/BPH) in… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study
BACKGROUND Radical whole-gland therapy can lead to significant genitourinary and rectal side-effects for men with localised… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up.
BACKGROUND Photoselective vaporization (PVP) with the GreenLight HPS 120-W laser (GLL) was recently introduced for treatment of… (More)
  • figure 1
  • table 1
  • table 3
  • table 2
  • figure 2
Is this relevant?
2009
2009
Psychometric analysis of international prostate symptom score for female lower urinary tract symptoms.
OBJECTIVES Although the International Prostate Symptom Score (IPSS) has often been used for female lower urinary tract symptoms… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
INTRODUCTION Benign prostatic hyperplasia (BPH) is associated with bothersome lower urinary tract symptoms (LUTS) and reduced… (More)
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 4
Is this relevant?
2001
2001
Reliability and validity of the International Prostate Symptom Score in a Malaysian population.
OBJECTIVE To validate the English version of the International Prostate Symptom Score (IPSS) in patients with and without urinary… (More)
Is this relevant?
1999
1999
The International Prostate Symptom score in both sexes: a urodynamics-based comparison.
The aim of our study was to determine the urodynamic basis for the observation that aging women report comparable benign… (More)
Is this relevant?
1996
1996
Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score.
OBJECTIVES To evaluate the relation between lower urinary tract symptoms (LUTS) as measured by the International Prostate Symptom… (More)
  • table I
  • table II
  • figure 1
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.
BACKGROUND Controversy regarding the relative efficacy of treatments for the relief of the symptoms of benign prostatic… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual…
OBJECTIVES To study the prevalence of symptoms of prostatism in the community and the correlation between these symptoms and age… (More)
Is this relevant?